Alternative Antibiotic Regimen in Periodontitis Treatment
NCT ID: NCT04353362
Last Updated: 2020-04-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
74 participants
INTERVENTIONAL
2017-04-01
2020-03-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Settings and Design: A before-after study design was adopted to evaluate the effects of 12 weeks of regular exercise on obese women grouped according to periodontal status, without a control group (no exercise).
Methods and Material: The study sample comprised fifteen patients without periodontitis (NP group) and 10 patients with chronic periodontitis (CP group), from whom periodontal parameters were measured and serum, saliva, and GCF samples were collected. Body mass index (BMI), anthropometric measurements, somatotype-motoric tests, and maximal oxygen consumption (VO2max) were recorded at baseline and after exercise.
Statistical analysis used: MedCalc was used for statistical analysis.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Non-surgical Periodontal Therapy on Oral and Gut Microbiome
NCT04580355
Amoxicillin and Metronidazole During Periodontal Treatment
NCT02954393
The Impact of Obesity on Nonsurgical Periodontal Therapy
NCT01405365
Amoxicillin and Metronidazole in Association With Non-surgical Therapy in Aggressive Periodontitis Treatment
NCT03933501
Dose and Duration of Metronidazole and Amoxicillin for Treatment of Chronic Periodontitis
NCT02735395
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ofloxacin group
Ofloxacin
400 mg, 1 time per day for 5 days
Amoxicillin plus Metronidazole group
Amoxicillin
500 mg, 3 times per day for 7 days
Metronidazole
500 mg, 3 times per day, for 7 days
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ofloxacin
400 mg, 1 time per day for 5 days
Amoxicillin
500 mg, 3 times per day for 7 days
Metronidazole
500 mg, 3 times per day, for 7 days
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
20 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Istanbul Medipol University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Begum Alkan
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Begum Alkan
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Istanbul Medipol
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.